• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺癌的F-FDG PET/CT图像中的放射组学分析能否预测激素受体状态?

Can Radiomics Analyses in F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

作者信息

Araz Mine, Soydal Çiğdem, Gündüz Pınar, Kırmızı Ayça, Bakırarar Batuhan, Dizbay Sak Serpil, Özkan Elgin

机构信息

Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey.

Ankara University Faculty of Medicine, Department of Pathology, Ankara, Turkey.

出版信息

Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):49-56. doi: 10.4274/mirt.galenos.2022.59140.

DOI:10.4274/mirt.galenos.2022.59140
PMID:35114752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8814554/
Abstract

OBJECTIVES

This study aimed to investigate the role of preoperative 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) radiomics features and metabolic parameters of primary breast tumors in predicting hormone receptor (HR) positivity.

METHODS

A total of 153 patients with breast carcinoma who underwent preoperative F-FDG PET/CT were included. All PET/CT images were retrospectively reevaluated. Radiomics features of primary breast lesions reflecting tumor heterogeneity as well as standardized uptake value (SUV) metrics (SUV, SUV, SUV, and SUV) and volumetric parameters such as metabolic tumor volume and total lesion glycolysis (TLG) were extracted by commercial texture analysis software package (LIFEx; https://www.lifexsoft.org/ index.php). WEKA and SPSS were used for statistical analysis. Binary logistic regression analysis was used to determine texture features predicting HR positivity. Accuracy, F-measure, precision, recall, and precision-recall curve area were used as data-mining performance criteria of texture features to predict HR positivity.

RESULTS

None of the radiomics parameters were significant in predicting HR status. Only SUV metrics and TLG were statistically important. Mean ± standard deviations for SUV, SUV, and SUV for the HR-negative group were significantly higher than those in the HR-positive group (6.73±4.36 vs. 5.20±3.32, p=0.027; 11.55±7.42 vs. 8.63±5.23, p=0.006; and 8.37±6.81 vs. 5.72±4.86; p=0.012). Cut-off values of SUV, SUV, and SUV for the prediction of HR positivity were 4.93, 8.35, and 6.02, respectively. Among data-mining methods, logistic regression showed the best performance with accuracy of 0.762.

CONCLUSION

In addition to the relatively limited number of patients in this study, radiomics parameters cannot predict the HR status of primary breast cancer. SUV levels of the HR-negative group were significantly higher than those of the HR-positive group. To clarify the role of metabolic and radiomics parameters in predicting HR status in breast cancer, further studies involving a larger study population are needed.

摘要

目的

本研究旨在探讨原发性乳腺肿瘤的术前18氟-氟脱氧葡萄糖(18F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)影像组学特征和代谢参数在预测激素受体(HR)阳性方面的作用。

方法

纳入153例术前行F-FDG PET/CT检查的乳腺癌患者。所有PET/CT图像均进行回顾性重新评估。使用商业纹理分析软件包(LIFEx;https://www.lifexsoft.org/index.php)提取反映肿瘤异质性的原发性乳腺病变的影像组学特征以及标准化摄取值(SUV)指标(SUV最大值、SUV平均值、SUV最小值和SUV峰值)和代谢肿瘤体积、总病变糖酵解(TLG)等体积参数。使用WEKA和SPSS进行统计分析。采用二元逻辑回归分析确定预测HR阳性的纹理特征。准确性、F值、精确率、召回率和精确率-召回率曲线面积用作纹理特征预测HR阳性的数据挖掘性能标准。

结果

影像组学参数在预测HR状态方面均无显著性。只有SUV指标和TLG具有统计学意义。HR阴性组的SUV最大值、SUV平均值和SUV峰值的均值±标准差显著高于HR阳性组(6.73±4.36 vs. 5.20±3.32,p = 0.027;11.55±7.42 vs. 8.63±5.23,p = 0.006;8.37±6.81 vs. 5.72±4.86;p = 0.012)。预测HR阳性的SUV最大值、SUV平均值和SUV峰值的截断值分别为4.93、8.35和6.02。在数据挖掘方法中,逻辑回归表现最佳,准确性为0.762。

结论

除本研究患者数量相对有限外,影像组学参数无法预测原发性乳腺癌的HR状态。HR阴性组的SUV水平显著高于HR阳性组。为阐明代谢和影像组学参数在预测乳腺癌HR状态中的作用,需要开展涉及更大研究人群的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e7/8814554/ef4da9ac991c/MIRT-31-49-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e7/8814554/ef4da9ac991c/MIRT-31-49-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e7/8814554/ef4da9ac991c/MIRT-31-49-g1.jpg

相似文献

1
Can Radiomics Analyses in F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?原发性乳腺癌的F-FDG PET/CT图像中的放射组学分析能否预测激素受体状态?
Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):49-56. doi: 10.4274/mirt.galenos.2022.59140.
2
Metabolic Tumor Burden Assessed by Dual Time Point [F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology.双时间点[F]FDG PET/CT评估局部晚期乳腺癌的代谢肿瘤负荷:与肿瘤生物学的关系
Mol Imaging Biol. 2017 Aug;19(4):636-644. doi: 10.1007/s11307-016-1034-x.
3
Ability of F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma.F-FDG PET/CT 影像组学特征鉴别乳腺癌与乳腺淋巴瘤的能力。
Contrast Media Mol Imaging. 2019 Feb 25;2019:4507694. doi: 10.1155/2019/4507694. eCollection 2019.
4
Radiomics analysis of pre-treatment [F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment.转移性结直肠癌患者姑息性全身治疗前 [F]FDG PET/CT 的放射组学分析。
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2307-2317. doi: 10.1007/s00259-018-4100-6. Epub 2018 Aug 9.
5
FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描用于预测雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌患者的预后:临床病理参数与包括肿瘤纹理分析在内的PET图像衍生指标的比较
Breast Cancer Res. 2017 Jan 5;19(1):3. doi: 10.1186/s13058-016-0793-2.
6
Radiomics Analysis of [F]-Fluorodeoxyglucose-Avid Thyroid Incidentalomas Improves Risk Stratification and Selection for Clinical Assessment.基于[F]-氟代脱氧葡萄糖摄取的甲状腺偶发瘤影像组学分析可改善风险分层,并有助于临床评估的选择。
Thyroid. 2021 Jan;31(1):88-95. doi: 10.1089/thy.2020.0224. Epub 2020 Jul 6.
7
Molecular subtype classification of breast cancer using established radiomic signature models based on F-FDG PET/CT images.基于 F-FDG PET/CT 图像的放射组学特征模型对乳腺癌进行分子亚型分类。
Front Biosci (Landmark Ed). 2021 Aug 30;26(9):475-484. doi: 10.52586/4960.
8
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?临床、组织学或免疫组化原发性肿瘤特征是否能转化为II/III期乳腺癌不同的(18)F-FDG PET/CT体积和异质性特征?
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1682-1691. doi: 10.1007/s00259-015-3110-x. Epub 2015 Jul 4.
9
Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.局灶性甲状腺代谢亢进偶发瘤的特征:一项使用F-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描参数的分析。
World J Clin Cases. 2022 Jan 7;10(1):155-165. doi: 10.12998/wjcc.v10.i1.155.
10
The correlation of F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.乳腺癌中 F-FDG PET/CT 代谢参数与临床病理因素及预后的相关性。
Clin Transl Oncol. 2021 Mar;23(3):620-627. doi: 10.1007/s12094-020-02457-w. Epub 2020 Jul 18.

引用本文的文献

1
Integrative radiomics clustering analysis to decipher breast cancer heterogeneity and prognostic indicators through multiparametric MRI.通过多参数磁共振成像进行综合放射组学聚类分析以解析乳腺癌异质性和预后指标。
NPJ Breast Cancer. 2024 Aug 7;10(1):72. doi: 10.1038/s41523-024-00678-8.
2
Dynomics: A Novel and Promising Approach for Improved Breast Cancer Prognosis Prediction.动态组学:一种用于改善乳腺癌预后预测的新颖且有前景的方法。
J Pers Med. 2023 Jun 15;13(6):1004. doi: 10.3390/jpm13061004.
3
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review.

本文引用的文献

1
Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience.乳腺癌中 Ki-67 增殖指数作为评估方法的函数:NordiQC 经验。
Appl Immunohistochem Mol Morphol. 2021 Feb 1;29(2):99-104. doi: 10.1097/PAI.0000000000000846.
2
Introduction to Radiomics.放射组学简介。
J Nucl Med. 2020 Apr;61(4):488-495. doi: 10.2967/jnumed.118.222893. Epub 2020 Feb 14.
3
PET/CT radiomics in breast cancer: Mind the step.乳腺癌的 PET/CT 影像组学:注意这一步。
基于正电子发射断层扫描的放射组学与人工智能在乳腺癌中的应用:系统综述。
Int J Mol Sci. 2022 Nov 2;23(21):13409. doi: 10.3390/ijms232113409.
4
Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.肿瘤PET成像中的放射组学:系统综述 - 第1部分,膈上癌症
Diagnostics (Basel). 2022 May 27;12(6):1329. doi: 10.3390/diagnostics12061329.
Methods. 2021 Apr;188:122-132. doi: 10.1016/j.ymeth.2020.01.007. Epub 2020 Jan 21.
4
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.乳腺癌中雌激素和孕激素受体检测:ASCO/CAP 指南更新。
J Clin Oncol. 2020 Apr 20;38(12):1346-1366. doi: 10.1200/JCO.19.02309. Epub 2020 Jan 13.
5
Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer.18F-FDG PET/CT图像的容积和影像组学结果与局部/局部晚期乳腺癌免疫组化预后因素的比较。
Nucl Med Commun. 2019 Jul;40(7):764-772. doi: 10.1097/MNM.0000000000001019.
6
Intratumoral heterogeneity in F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate.通过纹理分析评估乳腺癌F-FDG PET/CT中的瘤内异质性作为预测和预后替代指标
Ann Nucl Med. 2018 Jul;32(6):379-388. doi: 10.1007/s12149-018-1253-0. Epub 2018 Jun 5.
7
Texture analysis of high-resolution dedicated breast F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.高分辨率专用乳腺 F-FDG PET 图像的纹理分析与乳腺癌的免疫组织化学因素和亚型相关。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):196-206. doi: 10.1007/s00259-017-3830-1. Epub 2017 Sep 21.
8
[F]FDG PET/CT features for the molecular characterization of primary breast tumors.[F]FDG PET/CT 特征用于原发性乳腺癌的分子特征分析。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1945-1954. doi: 10.1007/s00259-017-3770-9. Epub 2017 Jul 15.
9
Metabolic Radiomics for Pretreatment F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis.代谢放射组学在 F-FDG PET/CT 预处理中的应用:局部晚期乳腺癌的特征、新辅助化疗反应和预后的组织病理学特征。
Sci Rep. 2017 May 8;7(1):1556. doi: 10.1038/s41598-017-01524-7.
10
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.一大群雌激素受体阳性乳腺癌患者中肿瘤特征、SUV测量值、代谢肿瘤体积、总病变糖酵解与通过F-FDG PET评估的纹理特征之间的相关性
Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1145-1154. doi: 10.1007/s00259-017-3641-4. Epub 2017 Feb 10.